Onkos Surgical, Inc. — SEC Form D Filing
Onkos Surgical, Inc. filed an SEC Form D on August 7, 2026, reporting $37.25M raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- August 7, 2026
- Amount reported
- $37.25M
- Industry
- Medical Devices
- Website
- https://onkossurgical.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Individuals with cancer and other complex orthopedic conditions require specialized solutions. Complex resection and reconstruction of long bones or the pelvis present challenges for surgeons.
Solution
Onkos Surgical provides precision orthopaedics, including antibacterial implant technology (NanoCept®), limb salvage systems (ELEOS™) to address soft tissue and implant loosening failures, personalized 3D solutions (My3D®) for reconstruction and joint preservation, and extendible prostheses (JTS) for pediatric bone tumor surgery.
Verdict
Investors backed this round because the company presented a specialized, integrated suite of orthopedic solutions for a complex, high-stakes medical niche, not because it offered a broad-market disruptive technology. They were implicitly betting on the steady adoption of purpose-built devices in oncology-driven orthopedics, where clinical outcomes outweigh minor cost differentials. Upside was limited by the inherently smaller patient population and the necessity of navigating complex regulatory pathways for each specialized device.
Source: SEC EDGAR Form D filing